DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to invest in for the next 2 years. On April 30, DexCom reported Q1 2026 revenue of $1.192 billion, representing a 15% year-over-year increase on a reported basis. Growth was driven by an 11% rise in US revenue and a 26% jump in international sales. The company also saw margin expansion, with GAAP operating income reaching $255.3 million, or 21.4% of revenue, an 850 basis point increase compared to Q1 2025.
Strategic highlights for the period included the expanded launch of the Dexcom G7 15-day CGM system and the introduction of enhanced features for the Stelo platform. Furthermore, clinical data presented at ATTD 2026 demonstrated that the Dexcom G7 significantly improved A1C levels for people with type 2 diabetes not using insulin.
Following the quarterly performance, DexCom Inc. (NASDAQ:DXCM) raised its full-year 2026 guidance for non-GAAP operating margin and adjusted EBITDA margin, now projecting 23% to 23.5% and 31% to 31.5%, respectively. The company reiterated its annual revenue forecast of $5.16 billion to $5.25 billion, reflecting 11% to 13% growth. As of March 31, Dexcom maintained a strong liquidity position with $2.42 billion in cash, cash equivalents, and marketable securities.
DexCom Inc. (NASDAQ:DXCM) is a medical device company that manufactures CGM systems to allow real-time health management control. It offers various medical devices and products, including Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.
While we acknowledge the potential of DXCM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
